What's new — by condition¶
Generated 2026-09-03 from the publication dates of every cited paper across all conditions.
Where the evidence is moving, and what specifically has moved. Conditions are ordered by how many of their cited papers appeared in the last three months — the top is the current frontier, the bottom is settled ground.
At a glance¶
| Condition | Newest cited paper | Last 3 months | Last year | Total cited |
|---|---|---|---|---|
| Depression | 2026-08-04 | 13 | 39 | 385 |
| Melanoma | 2026-08-04 | 11 | 61 | 630 |
| Chronic kidney disease | 2026-08-07 | 10 | 32 | 310 |
| Hypertensive heart disease | 2026-08-03 | 10 | 21 | 252 |
| Irritable bowel syndrome | 2026-08-09 | 9 | 40 | 366 |
| Hypertension | 2026-08-02 | 8 | 55 | 768 |
| Type 1 diabetes | 2026-08-03 | 8 | 23 | 259 |
| Masld | 2026-08-07 | 6 | 44 | 360 |
| Osteoarthritis | 2026-08-02 | 6 | 40 | 527 |
| Fibromyalgia | 2026-07-02 | 6 | 20 | 392 |
| Bipolar disorder | 2026-08-03 | 5 | 19 | 382 |
| Migraine | 2026-08-04 | 5 | 14 | 388 |
| ADHD | 2026-08-02 | 4 | 48 | 449 |
| Vascular dementia | 2026-08-02 | 4 | 27 | 417 |
| Anorexia nervosa | 2026-08-05 | 4 | 22 | 282 |
| Retinoblastoma | 2026-08-03 | 4 | 18 | 367 |
| Spinal stenosis | 2026-07-02 | 3 | 27 | 342 |
| Type 2 diabetes | 2026-08-02 | 3 | 16 | 246 |
| Stroke | 2026-08-02 | 3 | 10 | 380 |
| Colorectal adenocarcinoma | 2026-07-02 | 3 | 8 | 292 |
| Cataracts | 2026-07-02 | 2 | 34 | 451 |
| Alzheimers disease | 2026-08-01 | 2 | 22 | 366 |
| Degenerative disc disease | 2026-07-01 | 2 | 19 | 348 |
| Thoracic aortic aneurysm | 2026-08-14 | 2 | 18 | 341 |
| Rheumatoid arthritis | 2026-07-02 | 2 | 10 | 251 |
| Neuropathic pain | 2026-07-09 | 2 | 3 | 288 |
| Generalized anxiety disorder | 2026-06-05 | 1 | 21 | 393 |
| Lung adenocarcinoma | 2026-08-01 | 1 | 9 | 268 |
| Ptsd | 2026-07-03 | 1 | 9 | 383 |
| Ischemic heart disease | 2026-08-25 | 1 | 4 | 251 |
| Hepatocellular carcinoma | 2026-05-01 | 0 | 7 | 325 |
| COPD | 2026-06-01 | 0 | 3 | 295 |
| Lung squamous cell carcinoma | 2026-05-02 | 0 | 2 | 324 |
| Uterine adenosarcoma | 2026-06-02 | 0 | 2 | 66 |
| Asthma | 2025-12-01 | 0 | 1 | 394 |
By condition¶
Depression¶
last week: 0 · last month: 1 · last 2 months: 1 · last 3 months: 13 · last 6 months: 20 · last year: 39 · 385 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-04 | Resting-state fMRI-based machine learning for predicting SSRI treatment response in major depressive disorder — BMC Psychiatry (PMID 42552532) | biomarkers-and-treatment-prediction |
| 2026-07-03 | Reappraising lithium, triiodothyronine and second-generation antipsychotic augmentation treatment for major depression: a systematic review and meta-analysis with bias-adjustment analyses — BMJ Ment Health (PMID 42532626) | treatment-resistant-depression |
| 2026-07-03 | Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis — Front Psychiatry (PMID 42490943) | guidelines |
| 2026-07-03 | The use of patient-reported outcome measures in assessing the prevalence and tolerance of SSRI-related sexual dysfunction: a systematic review — J Sex Med (PMID 42466890) | antidepressant-pharmacology |
| 2026-07-03 | Ketamine alters the aperiodic EEG exponent in major depression: implications for cortical E/I balance and treatment prediction — Ther Adv Psychopharmacol (PMID 42403511) | biomarkers-and-treatment-prediction |
| 2026-07-02 | Transdiagnostic medication-associated weight gain across five effectiveness trials: a harmonized longitudinal cohort analysis of antipsychotics, antidepressants, and mood stabilizers — Prog Neuropsychopharmacol Biol Psychiatry (PMID 42492718) | antidepressant-pharmacology |
| 2026-07-01 | [Inflammatory depression: a review of advances in pathophysiology, clinical implications, and treatment] — Rev Med Inst Mex Seguro Soc (PMID 42447470) | biomarkers-and-treatment-prediction |
| 2026-07-01 | Post-SSRI Sexual Dysfunction (PSSD): A comprehensive review of epidemiology, pathophysiology, and clinical management — Int J Risk Saf Med (PMID 42430418) | antidepressant-pharmacology |
| 2026-07-01 | Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder: A Systematic Review and Network Meta-Analysis — J Evid Based Med (PMID 42383744) | neuromodulation |
| 2026-07-01 | Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis — JAMA Psychiatry (PMID 42090166) | clinical-trials-landscape, ketamine-and-glutamatergic-agents |
…and 3 more in the last 3 months — see the full recency page.
Melanoma¶
last week: 0 · last month: 1 · last 2 months: 6 · last 3 months: 11 · last 6 months: 35 · last year: 61 · 630 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-04 | A Multistep Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma — Cancer Res (PMID 41661679) | uveal-melanoma |
| 2026-08-01 | [(99m)Tc]Tc-Tilmanocept sentinel node biopsy and long-term outcomes in melanoma: A cohort study and literature review — Eur J Surg Oncol (PMID 42617582) | sentinel-node-and-nodal-management |
| 2026-08-01 | Systemic surveillance for uveal melanoma: Approach to optimization — PLoS One (PMID 42616744) | uveal-melanoma |
| 2026-08-01 | Missed Opportunities for Neoadjuvant Immunotherapy in Melanoma: Is it Time to Consider Ultrasound Staging for Newly Diagnosed Patients? — Ann Surg Oncol (PMID 42581274) | staging |
| 2026-08-01 | Population Skin Cancer Screening and Melanoma Mortality Rates — JAMA Dermatol (PMID 42268621) | guidelines, overview, screening-and-overdiagnosis |
| 2026-07-15 | Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study — Cancer (PMID 42411543) | adjuvant-therapy |
| 2026-07-02 | Efficacy, safety, and characteristics of adoptive tumor-infiltrating lymphocyte therapy in solid tumours: a systematic review and meta-analysis — Front Oncol (PMID 42558559) | cellular-therapy-and-resistance |
| 2026-07-01 | Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries — CA Cancer J Clin (PMID 42417444) | epidemiology-and-global-burden |
| 2026-07-01 | Impact of Multigene Panel Testing in High-Risk Uveal Melanoma Patients — Pigment Cell Melanoma Res (PMID 42415513) | germline-predisposition, uveal-melanoma |
| 2026-07-01 | Immune checkpoint inhibitor-induced myasthenia gravis and myocarditis: a fatal immune-related adverse event — Immunol Res (PMID 42384108) | red-flags-and-safety-concerns |
…and 1 more in the last 3 months — see the full recency page.
Chronic kidney disease¶
last week: 0 · last month: 1 · last 2 months: 5 · last 3 months: 10 · last 6 months: 18 · last year: 32 · 310 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-07 | Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis — Lancet Diabetes Endocrinol (PMID 42567173) | clinical-trials-landscape, glp1-and-emerging-therapy |
| 2026-08-02 | Liberal fruit and vegetable intake in patients with advanced CKD with or without Sodium zirconium cyclosilicate — J Ren Nutr (PMID 42636918) | diet-and-nutrition |
| 2026-08-01 | Apolipoprotein L1 Gene Genotype and Kidney Outcomes After Living Kidney Donation — JAMA Intern Med (PMID 42329639) | race-and-the-egfr-equation |
| 2026-07-31 | KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP) — Nephrol Dial Transplant (PMID 41604211) | anaemia-of-ckd |
| 2026-07-21 | Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial — JAMA (PMID 42246414) | clinical-trials-landscape, inherited-and-glomerular-disease |
| 2026-06-09 | 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines — J Am Coll Cardiol (PMID 42265997) | guidelines |
| 2026-06-09 | 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines — Circulation (PMID 42263157) | guidelines |
| 2026-06-05 | Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY) — Lancet (PMID 42248158) | guidelines, mineralocorticoid-receptor-antagonists |
| 2026-06-04 | Finerenone in Persons with Chronic Kidney Disease without Diabetes — N Engl J Med (PMID 42246672) | clinical-trials-landscape, diabetic-kidney-disease, guidelines, mineralocorticoid-receptor-antagonists |
| 2026-06-04 | Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial — Lancet (PMID 42242268) | clinical-trials-landscape, glp1-and-emerging-therapy, inherited-and-glomerular-disease |
Hypertensive heart disease¶
last week: 0 · last month: 0 · last 2 months: 10 · last 3 months: 10 · last 6 months: 13 · last year: 21 · 252 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-03 | Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study — Lancet (PMID 42669305) | epidemiology-and-burden, heart-failure-management |
| 2026-08-03 | Time in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trials — Eur J Heart Fail (PMID 42669134) | diastolic-dysfunction-and-hfpef |
| 2026-08-02 | Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial — Circulation (PMID 42666029) | lifestyle-and-population-prevention |
| 2026-08-02 | Hypertensive crisis in the elderly: epidemiological, clinical and outcome: EDEN-47 study — Gerontology (PMID 42664163) | red-flags-and-safety-concerns |
| 2026-08-02 | Non-linear associations between blood pressure and clinical outcomes in atrial fibrillation: A systematic review and dose-response meta-analysis — Europace (PMID 42663497) | arrhythmia-and-atrial-remodeling |
| 2026-08-02 | Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy — JAMA (PMID 42663420) | diagnosis-and-phenotyping |
| 2026-08-02 | Personalized evaluation of NT-proBNP and clinical characteristics in suspected heart failure: the PRECISE-HF study — Eur Heart J (PMID 42663089) | biomarkers-and-imaging-markers |
| 2026-08-02 | 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA) — Eur Heart J (PMID 42661426) | guidelines |
| 2026-08-02 | 2026 ESC Guidelines for the management of heart failure — Eur Heart J (PMID 42661420) | guidelines, heart-failure-management |
| 2026-08-02 | Achieved home systolic blood pressure and cardiovascular risk in older hypertensive patients — Hypertens Res (PMID 42660976) | blood-pressure-targets |
Irritable bowel syndrome¶
last week: 0 · last month: 1 · last 2 months: 5 · last 3 months: 9 · last 6 months: 16 · last year: 40 · 366 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-09 | Systematic Review and Meta-Analysis: Plant-Based Therapy for Irritable Bowel Syndrome — Phytother Res (PMID 42572206) | antispasmodics-and-peppermint |
| 2026-08-02 | Long-term microbiome and clinical effects of a microbiome-guided personalized diet versus low-FODMAP diet in irritable bowel syndrome: A 12-month follow-up randomized controlled trial — Gut Microbes (PMID 42623122) | dietary-therapy |
| 2026-08-01 | Rome V global epidemiology and validation survey: prevalence of disorders of gut-brain interaction and comparison with the Rome IV global epidemiology study — Gut (PMID 42613194) | diagnosis-and-rome-criteria, epidemiology-and-burden, overlap-with-functional-dyspepsia, overview |
| 2026-08-01 | Fiber Supplementation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Gastroenterology (PMID 42600900) | dietary-therapy |
| 2026-07-08 | Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility — Gut (PMID 41558814) | brain-gut-axis-and-visceral-hypersensitivity |
| 2026-07-03 | Cost-of-Illness of Irritable Bowel Syndrome: A Systematic Review — J Gastroenterol Hepatol (PMID 42538760) | epidemiology-and-burden, overview, quality-of-life-and-stigma |
| 2026-07-02 | The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy study — Lancet Gastroenterol Hepatol (PMID 42392123) | clinical-trials-landscape, diagnosis-and-rome-criteria, guidelines, overview |
| 2026-07-01 | Pathophysiology of irritable bowel syndrome — Lancet Gastroenterol Hepatol (PMID 42462748) | brain-gut-axis-and-visceral-hypersensitivity, overlap-with-functional-dyspepsia, overview, post-infectious-ibs |
| 2026-06-09 | Physician-Patient Discordance in Bristol Stool Scale Classification and Overall IBS Burden Assessment — Am J Gastroenterol (PMID 42289094) | diagnosis-and-rome-criteria |
Hypertension¶
last week: 0 · last month: 0 · last 2 months: 3 · last 3 months: 8 · last 6 months: 20 · last year: 55 · 768 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-02 | Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial — Circulation (PMID 42666029) | adherence-and-implementation |
| 2026-08-02 | Baxdrostat: First Approval — Drugs (PMID 42625106) | pharmacological-therapy, resistant-and-refractory-hypertension |
| 2026-08-01 | Prevalence of adherence to antihypertensive treatment: a comparison of drug biochemical analysis and the self-report scale — Clin Hypertens (PMID 42564271) | adherence-and-implementation |
| 2026-07-03 | Association of a CCB-Related Pharmacogenomics-Guided Strategy with Blood Pressure Outcomes and Short-Term Safety in Chinese Patients with Hypertension: A Secondary Exploratory Analysis of Two Randomized Cohorts — Drug Healthc Patient Saf (PMID 42553612) | genetics-and-monogenic-forms |
| 2026-07-01 | Blood Pressure Control With Clevidipine Is Associated With Hematoma Volume Reduction in Acute Hypertensive Intracerebral Hemorrhage: A Single-Center Prospective Cohort Study — Eur J Neurol (PMID 42397158) | hypertensive-emergencies |
| 2026-07-01 | Innovative Device-Based Treatments for Hypertension — Am J Hypertens (PMID 41344842) | device-and-interventional-therapy |
| 2026-06-09 | 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines — J Am Coll Cardiol (PMID 42265997) | lifestyle-and-dietary-management, special-populations |
| 2026-06-09 | 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines — Circulation (PMID 42263157) | special-populations |
Type 1 diabetes¶
last week: 0 · last month: 0 · last 2 months: 3 · last 3 months: 8 · last 6 months: 11 · last year: 23 · 259 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-03 | Simultaneous Pancreas-Kidney Transplantation Versus Kidney Transplantation Alone in Type 1 Diabetes: Does Pancreas Transplantation Improve Clinical Outcomes? A Systematic Review and Exploratory Meta-Analysis — Med Sci (Basel) (PMID 42646588) | beta-cell-replacement |
| 2026-08-02 | Gene-edited hypoimmune islets as a cure for type 1 diabetes: a review of the immunological challenges — Expert Opin Biol Ther (PMID 42626948) | beta-cell-replacement |
| 2026-08-02 | Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care — Diabetes Technol Ther (PMID 42626886) | complications |
| 2026-07-02 | Epidemiological and clinical insights from Type 1 Diabetes Global Registries: A systematic review and meta-analysis — Diabetes Metab Syndr (PMID 42551241) | complications, epidemiology-and-burden, overview |
| 2026-07-02 | Global prevalence and correlates of diabetes distress in type 1 diabetes: A systematic review and meta-analysis — Diabetes Res Clin Pract (PMID 42486409) | overview, patient-experience-and-advocacy, psychosocial-and-behavioral |
| 2026-07-01 | Contemporary Diabetes Technology and the Patient Experience — JAMA Netw Open (PMID 42479430) | patient-experience-and-advocacy |
| 2026-07-01 | Reduced Prevalence of Impaired Awareness of Hypoglycemia Over Two Decades in Population-Based Samples of Youth With Type 1 Diabetes — Diabetes Care (PMID 42138725) | hypoglycemia |
| 2026-07-01 | Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive Adults — Diabetes Care (PMID 42090204) | screening-and-early-detection, staging-and-natural-history |
Masld¶
last week: 0 · last month: 1 · last 2 months: 3 · last 3 months: 6 · last 6 months: 12 · last year: 44 · 360 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-07 | Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds — Hepatol Commun (PMID 42566274) | noninvasive-assessment, red-flags-and-safety-concerns |
| 2026-08-01 | Lived Experience, Concerns, and Support Needs of Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Qualitative Study — Healthcare (Basel) (PMID 42651339) | patient-experience-and-advocacy |
| 2026-08-01 | Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open-Label Trial — Diabetes Obes Metab (PMID 42605535) | masld-and-type-2-diabetes |
| 2026-07-02 | Understanding MASLD and diabetes through lived experience — Diabetologia (PMID 42525136) | patient-experience-and-advocacy |
| 2026-07-01 | A qualitative study on the self-management experience and needs of postmenopausal patients with metabolic dysfunction-associated steatotic liver disease from the perspective of active health — Front Public Health (PMID 42529177) | patient-experience-and-advocacy |
| 2026-07-01 | Recompensation of decompensated cirrhosis in a spectrum of metabolic dysfunction-related steatotic liver disease, with PEth-corroborated alcohol abstinence and modification of cardiometabolic risk factors — Hepatology (PMID 42467948) | cirrhosis-and-decompensation |
Osteoarthritis¶
last week: 0 · last month: 0 · last 2 months: 2 · last 3 months: 6 · last 6 months: 16 · last year: 40 · 527 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-02 | Disease-modifying antirheumatic drugs for hand osteoarthritis: A systematic review and network meta-analysis — Hand Surg Rehabil (PMID 42632595) | clinical-trials-landscape |
| 2026-07-05 | Efficacy and safety of lorecivivint for the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials — J Orthop Surg (Hong Kong) (PMID 42402776) | disease-modifying-therapies |
| 2026-07-02 | The effect of pregabalin on pain and function in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials — Inflammopharmacology (PMID 42481863) | pain-mechanisms-and-sensitization |
| 2026-07-01 | Transcranial direct current stimulation for pain threshold in knee osteoarthritis: a mechanism-oriented systematic review and meta-analysis of randomized controlled trials — Front Physiol (PMID 42523626) | pain-mechanisms-and-sensitization |
| 2026-07-01 | Differentiating septic arthritis from non-infectious inflammatory causes of acute monoarticular arthritis in children: A machine learning approach based on routine laboratory tests — Ir J Med Sci (PMID 42467382) | red-flags-and-safety-concerns |
| 2026-07-01 | Efficacy of Intra-Articular Corticosteroid Injection for Hip Osteoarthritis: A Systematic Review With Meta-Analysis — J Arthroplasty (PMID 42462884) | biomarkers-and-imaging-markers |
Fibromyalgia¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 6 · last 6 months: 10 · last year: 20 · 392 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-02 | Trends in incidence, patient characteristics, healthcare use, and medication in fibromyalgia: A large Israeli cohort study — Semin Arthritis Rheum (PMID 42551405) | epidemiology |
| 2026-07-02 | The genetic architecture of fibromyalgia across 2.5 million individuals — Nat Med (PMID 42521817) | clinical-trials-landscape, comorbidities-and-overlap, genetics-and-risk-factors, omics-and-emerging-science |
| 2026-07-02 | Sublingual Cyclobenzaprine for Fibromyalgia: Pharmacokinetic Rationale, Clinical Evidence, and Place in Therapy — Curr Pain Headache Rep (PMID 42479282) | clinical-trials-landscape, guidelines, pharmacologic-therapy |
| 2026-07-01 | Absence of a Consistent Gut or Oral Microbial Signature in Fibromyalgia Under Strictly Controlled Clinical Conditions: A Multi-Compartment 16S rRNA Analysis — Pain Physician (PMID 42550534) | biomarkers, omics-and-emerging-science |
| 2026-07-01 | fAI-BRO: a multimodal AI decision-support system to address diagnostic delay in fibromyalgia syndrome — RMD Open (PMID 42442924) | biomarkers, omics-and-emerging-science, patient-experience-and-advocacy |
| 2026-06-04 | Fibromyalgia in systemic autoimmune rheumatic diseases: a mixed-methods study of patient and clinician perspectives — Rheumatol Int (PMID 42236570) | patient-experience-and-advocacy |
Bipolar disorder¶
last week: 0 · last month: 0 · last 2 months: 5 · last 3 months: 5 · last 6 months: 10 · last year: 19 · 382 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-03 | Retinal electrophysiology in mood disorders: Toward clinically relevant biomarkers. A systematic review and meta-analysis — J Affect Disord (PMID 42669383) | biomarkers-and-digital-phenotyping |
| 2026-08-02 | Examination of the intersection of bipolar I disorder status and cannabis use disorder severity in relation to health-related quality-of-life and lifetime suicide attempts — J Psychiatr Res (PMID 42664567) | suicide-mortality-and-physical-health |
| 2026-08-02 | Higher frequencies of CNV deletions in bipolar disorder among Chinese Population — Mol Psychiatry (PMID 42661060) | genetics-and-neurobiology |
| 2026-08-01 | Risk of heart failure in patients with schizophrenia or bipolar disorder: A systematic review and meta-analysis — Pak J Med Sci (PMID 42668911) | suicide-mortality-and-physical-health |
| 2026-08-01 | Cause-specific mortality due to physical illness in severe mental disorders in Europe: a population-based multi-country cohort study — Lancet Public Health (PMID 42480565) | suicide-mortality-and-physical-health |
Migraine¶
last week: 0 · last month: 1 · last 2 months: 1 · last 3 months: 5 · last 6 months: 7 · last year: 14 · 388 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-04 | Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience — Toxins (Basel) (PMID 42646770) | preventive-treatment |
| 2026-07-02 | Lamotrigine prophylaxis is associated with reduced aura frequency in patients with burdensome migraine aura: a retrospective observational study — Front Neurol (PMID 42591364) | aura-and-cortical-spreading-depolarization |
| 2026-07-02 | Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial — Lancet Neurol (PMID 42492556) | clinical-trials-landscape, overview, preventive-treatment |
| 2026-07-02 | Cerebrovascular risk with calcitonin gene-related peptide monoclonal antibodies versus onabotulinumtoxinA in patients with migraine: A real-world pharmacoepidemiologic study in the National Institutes of Health All of Us Research Program — Cephalalgia (PMID 42390441) | comorbidity-and-vascular-risk |
| 2026-07-01 | Migraine-advanced preventative treatments: the British Association for the Study of Headache Clinical Practice Recommendations and Consensus Guidance — J Neurol Neurosurg Psychiatry (PMID 42469019) | guidelines |
ADHD¶
last week: 0 · last month: 0 · last 2 months: 1 · last 3 months: 4 · last 6 months: 14 · last year: 48 · 449 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-02 | Verbal fluency in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis — Acta Psychol (Amst) (PMID 42659788) | comorbidity-and-differential-diagnosis |
| 2026-07-01 | Consensus Statement on Digital Health and Attention-Deficit/Hyperactivity Disorder by the European Network for ADHD (EUNETHYDIS): Modified Delphi Study — J Med Internet Res (PMID 42462051) | overview |
| 2026-07-01 | Real-world clinical validation of brainstem-based ocular biomarkers for ADHD classification in children and adults — Sci Rep (PMID 42448769) | biomarkers |
| 2026-06-09 | Mortality in people with attention-deficit/hyperactivity disorder (ADHD): Examining how risk is embodied in a pooling of two prospective cohort studies — medRxiv (PMID 42326778) | long-term-outcomes-and-quality-of-life |
Vascular dementia¶
last week: 0 · last month: 0 · last 2 months: 2 · last 3 months: 4 · last 6 months: 9 · last year: 27 · 417 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-02 | Pharmacological interventions targeting cognition and related clinical outcomes in vascular dementia: a systematic review and meta-analysis of randomized controlled trials — Eur J Clin Pharmacol (PMID 42635820) | overview, treatment |
| 2026-08-01 | Intensive versus standard blood pressure control and overall brain small vessel disease burden: a post-hoc analysis of the SPRINT randomized clinical trial — EClinicalMedicine (PMID 42614618) | clinical-trials-landscape, overview, prevention-and-risk-factor-control |
| 2026-07-03 | Isosorbide Mononitrate/Cilostazol for Lacunar Cerebral Small Vessel Disease-Outcomes at 6 Months in the LACI-2 Randomized Controlled Trial — J Am Heart Assoc (PMID 42535538) | treatment |
| 2026-07-01 | Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial — Lancet (PMID 42442374) | prevention-and-risk-factor-control |
Anorexia nervosa¶
last week: 0 · last month: 1 · last 2 months: 2 · last 3 months: 4 · last 6 months: 10 · last year: 22 · 282 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-05 | An Invited Updated Systematic Review and Meta-Analysis Comparing Atypical Anorexia Nervosa and Anorexia Nervosa — Int J Eat Disord (PMID 42557659) | diagnosis-and-classification, epidemiology-and-incidence, guidelines, medical-complications, mortality-and-long-term-outcome, overview, patient-experience-and-advocacy, red-flags-and-safety-concerns |
| 2026-07-06 | Stakeholder views on the proposed criteria for 'terminal anorexia': a mixed-methods study — Eat Disord (PMID 42410953) | patient-experience-and-advocacy, severe-enduring-illness-and-compulsory-treatment |
| 2026-07-01 | Theta burst stimulation of extrastriate body area for body perception in anorexia nervosa: a randomized controlled trial — Transl Psychiatry (PMID 42386712) | neuromodulation-and-experimental-therapy |
| 2026-07-01 | Excess Mortality Among Patients With Anorexia Nervosa Treated Involuntarily — Int J Eat Disord (PMID 42383339) | clinical-trials-landscape, guidelines, mortality-and-long-term-outcome, red-flags-and-safety-concerns, severe-enduring-illness-and-compulsory-treatment |
Retinoblastoma¶
last week: 0 · last month: 0 · last 2 months: 1 · last 3 months: 4 · last 6 months: 5 · last year: 18 · 367 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-03 | Intra-arterial chemotherapy for retinoblastoma: a structured narrative review — World J Pediatr Surg (PMID 42553724) | intra-arterial-chemotherapy |
| 2026-07-03 | Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma — Ophthalmology (PMID 42397330) | enucleation-and-high-risk-pathology |
| 2026-07-02 | Retinoblastoma presenting as congenital glaucoma — BMJ Case Rep (PMID 42486661) | classification-and-staging |
| 2026-07-01 | Global retinoblastoma service availability in 2024 and equity trends since 2017 — Br J Ophthalmol (PMID 42463304) | global-access-and-outcome-disparity, systemic-chemotherapy |
Spinal stenosis¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 3 · last 6 months: 3 · last year: 27 · 342 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-02 | Comparative Clinical Outcomes of Non-surgical and Surgical Treatment Methods for Lumbar Canal Stenosis: A Systematic Review — Cureus (PMID 42544109) | conservative-and-rehabilitation-care |
| 2026-07-01 | Preoperative metabolite ratio improves prediction of postoperative recovery in degenerative cervical myelopathy: a prospective cohort study — Spine J (PMID 42462976) | biomarkers-and-digital-mobility |
| 2026-07-01 | Smartphone-based kinematic biomarkers for degenerative cervical myelopathy screening robust to physiological aging — NPJ Digit Med (PMID 42448819) | biomarkers-and-digital-mobility |
Type 2 diabetes¶
last week: 0 · last month: 0 · last 2 months: 2 · last 3 months: 3 · last 6 months: 5 · last year: 16 · 246 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-02 | Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data — Nephrol Dial Transplant (PMID 42658186) | clinical-trials-landscape, incretin-therapies, sglt2-inhibitors-and-kidney-heart |
| 2026-08-01 | Promoting Stigma-Free Language in Type 2 Diabetes Care Among Primary Care Clinicians: Randomized Controlled Pilot Trial — JMIR Diabetes (PMID 42579884) | patient-experience-and-advocacy |
| 2026-07-02 | The comparative effectiveness of bariatric operations versus GLP-1 RAs: a systematic review and meta-analysis — Surg Obes Relat Dis (PMID 42660781) | metabolic-surgery, remission-and-weight-management |
Stroke¶
last week: 0 · last month: 0 · last 2 months: 2 · last 3 months: 3 · last 6 months: 8 · last year: 10 · 380 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-02 | 2026 Guideline for Adult Stroke Rehabilitation and Recovery: A Guideline From the American Heart Association and American Stroke Association — Stroke (PMID 42657476) | guidelines, overview, patient-experience-and-advocacy, rehabilitation-and-recovery |
| 2026-07-06 | Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial — Stroke (PMID 42403344) | clinical-trials-landscape |
| 2026-06-09 | Endovascular Thrombectomy in Medium and Distal Vessel Occlusions: A Focused Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee — Stroke Vasc Interv Neurol (PMID 42404835) | guidelines |
Colorectal adenocarcinoma¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 3 · last 6 months: 4 · last year: 8 · 292 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-02 | Disparities in colonoscopy adherence and neoplasia detection after positive fecal immunochemical test: a retrospective matched cohort study — Cancer Causes Control (PMID 42517977) | screening-and-early-detection |
| 2026-07-02 | Common analysis pitfalls in longitudinal ctDNA studies: lead time, sensitivity and immortal time bias — EBioMedicine (PMID 42508231) | biomarkers-and-liquid-biopsy |
| 2026-07-01 | Thermal ablation versus liver resection for small colorectal liver metastases (≤ 3 cm): a systematic review and meta-analysis of randomized and propensity score-matched studies — Surg Endosc (PMID 42463528) | liver-and-lung-metastasis |
Cataracts¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 2 · last 6 months: 11 · last year: 34 · 451 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-02 | Evaluation of Intraocular Lens Power Calculation Formulas for Highly Myopic Eyes: A Systematic Review and Network Meta-Analysis — J Clin Med (PMID 42589896) | iol-power-calculation |
| 2026-07-01 | Falling short of the target: effective cataract surgical coverage and the road to 2030 — Int J Ophthalmol (PMID 42382972) | access-equity-and-service-delivery, epidemiology-and-global-burden |
Alzheimers disease¶
last week: 0 · last month: 0 · last 2 months: 1 · last 3 months: 2 · last 6 months: 9 · last year: 22 · 366 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-01 | The Experience of Stigma Within the Young Onset Dementia (YOD) Population: A Systematic Review of Qualitative Research — Health Expect (PMID 42478735) | patient-experience-and-advocacy |
| 2026-07-01 | Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease — JAMA Neurol (PMID 42189519) | fluid-biomarkers, imaging-and-neuropathology |
Degenerative disc disease¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 2 · last 6 months: 7 · last year: 19 · 348 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-01 | Convergent validity and responsiveness of the 9-item PROMIS-29 derived low back pain impact score — J Pain (PMID 42471169) | outcomes-and-measurement |
| 2026-07-01 | Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials — Neurosurg Focus (PMID 42385251) | fusion-and-disc-replacement |
Thoracic aortic aneurysm¶
last week: 0 · last month: 1 · last 2 months: 2 · last 3 months: 2 · last 6 months: 8 · last year: 18 · 341 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-14 | The aorta in Marfan syndrome: from molecular mechanisms to mechanobiological dysfunction — Cardiovasc Res (PMID 42140666) | animal-models, hemodynamics-and-biomechanics, pathophysiology |
| 2026-07-08 | From survival to lifelong care: The role of patient organisations in aortic dissection — Am Heart J Plus (PMID 42491301) | patient-experience-and-advocacy |
Rheumatoid arthritis¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 2 · last 6 months: 4 · last year: 10 · 251 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-02 | Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trial — Lancet Rheumatol (PMID 42392130) | clinical-trials-landscape, overview, preclinical-autoimmunity-and-prevention |
| 2026-07-01 | 2024 Update of the Asia-Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management — Int J Rheum Dis (PMID 42362943) | guidelines |
Neuropathic pain¶
last week: 0 · last month: 0 · last 2 months: 1 · last 3 months: 2 · last 6 months: 2 · last year: 3 · 288 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-09 | PROSPER: a phase III trial of lecithinized superoxide dismutase to prevent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer — ESMO Gastrointest Oncol (PMID 42583153) | chemotherapy-and-toxic-neuropathy |
| 2026-07-01 | New insight into RNA biomarkers in neuropathic pain: a clinician-neuroscientist roadmap to translational testing and treatment monitoring a clinical review — Front Pain Res (Lausanne) (PMID 42534835) | biomarkers |
Generalized anxiety disorder¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 1 · last 6 months: 5 · last year: 21 · 393 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-06-05 | Self-Guided Internet-Based Mindfulness-Informed Stress Management for Generalized Anxiety Disorder: Randomized Controlled Trial With Longitudinal Network Analysis — J Med Internet Res (PMID 42247657) | digital-and-remote-delivery |
Lung adenocarcinoma¶
last week: 0 · last month: 0 · last 2 months: 1 · last 3 months: 1 · last 6 months: 3 · last year: 9 · 268 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-01 | Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3 — J Clin Oncol (PMID 42607282) | guidelines |
Ptsd¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 1 · last 6 months: 4 · last year: 9 · 383 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-07-03 | Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial — Commun Med (Lond) (PMID 42533157) | clinical-trials-landscape, mdma-and-psychedelic-assisted-therapy |
Ischemic heart disease¶
last week: 0 · last month: 1 · last 2 months: 1 · last 3 months: 1 · last 6 months: 2 · last year: 4 · 251 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-25 | Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023 — JAMA (PMID 42525403) | biomarkers, epidemiology-and-global-burden, lipid-lowering, overview |
Hepatocellular carcinoma¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 0 · last 6 months: 2 · last year: 7 · 325 cited in total · full recency page
Nothing in the last 3 months; newest of the past year:
| Published | Paper | Cited on |
|---|---|---|
| 2026-05-01 | Hepatocellular carcinoma attributable to hepatitis B, hepatitis C and other risk factors at global, regional and national levels: an updated systematic review and meta-analysis — Gut (PMID 42135055) | cirrhosis-and-risk-stratification, epidemiology-and-etiology, overview |
| 2026-05-01 | Second-line TKI after first-line immunotherapy-based treatment in advanced HCC: Reconstructed IPD meta-analysis — JHEP Rep (PMID 42128139) | systemic-therapy |
| 2026-01-02 | Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma — J Hepatol (PMID 41580093) | clinical-trials-landscape, surgical-resection-and-ablation |
| 2025-11-06 | Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study) — JHEP Rep (PMID 41624484) | surveillance-and-early-detection |
| 2025-11-01 | Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials — Ther Adv Gastroenterol (PMID 41268044) | locoregional-therapy |
COPD¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 0 · last 6 months: 1 · last year: 3 · 295 cited in total · full recency page
Nothing in the last 3 months; newest of the past year:
| Published | Paper | Cited on |
|---|---|---|
| 2026-06-01 | Coexistence of COPD or asthma in patients with bronchiectasis: a systematic review and meta-analysis — BMC Pulm Med (PMID 42321713) | comorbidity-and-systemic-effects |
| 2026-02-02 | Underrepresentation of Women in COPD Pharmacologic Trials Relative to Disease Burden: A Systematic Review and Meta-Analysis — Int J Chron Obstruct Pulmon Dis (PMID 41773232) | clinical-trials-landscape |
| 2025-11-04 | Reassessing the link between e-cigarette use and COPD: addressing critical methodological and conceptual flaws — NPJ Prim Care Respir Med (PMID 41188266) | smoking-pollution-and-occupational-risk |
Lung squamous cell carcinoma¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 0 · last 6 months: 2 · last year: 2 · 324 cited in total · full recency page
Nothing in the last 3 months; newest of the past year:
| Published | Paper | Cited on |
|---|---|---|
| 2026-05-02 | Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1 — J Clin Oncol (PMID 42190141) | guidelines, systemic-therapy |
| 2026-04-01 | Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study — Cancer Cell (PMID 41999747) | failed-and-frontier-targets |
Uterine adenosarcoma¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 0 · last 6 months: 1 · last year: 2 · 66 cited in total · full recency page
Nothing in the last 3 months; newest of the past year:
| Published | Paper | Cited on |
|---|---|---|
| 2026-06-02 | Fertility-sparing strategy in a rare case of uterine adenosarcoma and consecutive spontaneous pregnancy and livebirth — Arch Gynecol Obstet (PMID 42334466) | patient-experience-and-advocacy |
| 2026-01-02 | ESR1::NCOA2/3 fusions in uterine neoplasms with adenosarcoma-like morphology: clinicopathologic and molecular features of 12 cases and review of the literature — Virchows Arch (PMID 41555057) | molecular-and-genomic-features |
Asthma¶
last week: 0 · last month: 0 · last 2 months: 0 · last 3 months: 0 · last 6 months: 0 · last year: 1 · 394 cited in total · full recency page
Nothing in the last 3 months; newest of the past year:
| Published | Paper | Cited on |
|---|---|---|
| 2025-12-01 | Decreasing inhaled corticosteroids in pregnancy increases the risk for asthma exacerbations: time for new approaches to solve a decades-old problem — Eur Respir J (PMID 41412710) | pregnancy-and-reproductive-health |
Recency is not quality — an old paper is often the definitive one, and a new paper may not replicate. This shows movement, not merit. Each condition's own recency page adds the full age breakdown and flags which of its pages rest on the freshest evidence.